Veverimer

Unassigned

New Medicines

Metabolic acidosis in patients with chronic kidney disease

Information

New molecular entity
Tricida
Tricida

Development and Regulatory status

Phase III Clinical Trials
Phase III Clinical Trials
Phase III Clinical Trials

Category

Non-absorbed, orally-administered polymer
Metabolic acidosis becomes more common with advancing stages of CKD. The prevalence of a serum bicarbonate concentration of <22 mEq/L, for example, is <5% in CKD stages 1 and 2 and increases linearly to approximately 25% in patients with non-dialysis dependent CKD stage G5 [2].
Metabolic acidosis in patients with chronic kidney disease
Oral